Condition
Recurrence Tumor clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Recurrence Tumor clinical trials that are recruiting, at sites in 2 countries (most in Portugal (1), Switzerland (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Trimipramine with atezolizumab and bevacizumab for recurrent glioblastoma
Researchers will try whether adding the antidepressant trimipramine to the immunotherapy atezolizumab plus bevacizumab helps people with recurrent glioblastoma.
-
New tool to select liver transplant candidates for liver cancer
This study is testing a new tool to see if it can help doctors choose more patients with liver cancer for liver transplants, even if they don't meet the usual criteria.
Related topics
Quick answers
How many Recurrence Tumor clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Portugal (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.